Core Points - The newly revised Infectious Disease Prevention Law will take effect on September 1, 2025, enhancing public health legal protections and risk management capabilities in China [1] - The law consists of 9 chapters and 115 articles, emphasizing the leadership of the Communist Party, prioritizing people's lives, and advocating for a combination of prevention and treatment [1] - The law aims to establish a robust public health system led by medical institutions, improving core capabilities in disease monitoring, emergency response, testing, and medical treatment [1] - It clarifies responsibilities among various stakeholders, including government departments, disease control agencies, medical institutions, and individuals, enhancing collaborative mechanisms for disease prevention [1] Industry Implications - The law reflects a commitment to modernizing public health governance capabilities in China, emphasizing legal adaptability and foresight in public health [2] - The implementation of a health-first development strategy aims to strengthen the public health system and promote collaborative governance and integration of medical and preventive measures [2]